These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 30563940)

  • 21. Complete and Partial Lecithin:Cholesterol Acyltransferase Deficiency Is Differentially Associated With Atherosclerosis.
    Oldoni F; Baldassarre D; Castelnuovo S; Ossoli A; Amato M; van Capelleveen J; Hovingh GK; De Groot E; Bochem A; Simonelli S; Barbieri S; Veglia F; Franceschini G; Kuivenhoven JA; Holleboom AG; Calabresi L
    Circulation; 2018 Sep; 138(10):1000-1007. PubMed ID: 29748187
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A kindred with fish eye disease, corneal opacities, marked high-density lipoprotein deficiency, and statin therapy.
    Dimick SM; Sallee B; Asztalos BF; Pritchard PH; Frohlich J; Schaefer EJ
    J Clin Lipidol; 2014; 8(2):223-30. PubMed ID: 24636183
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expression of human lecithin-cholesterol acyltransferase in transgenic mice. Effect of human apolipoprotein AI and human apolipoprotein all on plasma lipoprotein cholesterol metabolism.
    Francone OL; Gong EL; Ng DS; Fielding CJ; Rubin EM
    J Clin Invest; 1995 Sep; 96(3):1440-8. PubMed ID: 7657816
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Beta2-adrenergic activity modulates vascular tone regulation in lecithin:cholesterol acyltransferase knockout mice.
    Manzini S; Pinna C; Busnelli M; Cinquanta P; Rigamonti E; Ganzetti GS; Dellera F; Sala A; Calabresi L; Franceschini G; Parolini C; Chiesa G
    Vascul Pharmacol; 2015 Nov; 74():114-121. PubMed ID: 26254103
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impact of apolipoprotein A1- or lecithin:cholesterol acyltransferase-deficiency on white adipose tissue metabolic activity and glucose homeostasis in mice.
    Xepapadaki E; Maulucci G; Constantinou C; Karavia EA; Zvintzou E; Daniel B; Sasson S; Kypreos KE
    Biochim Biophys Acta Mol Basis Dis; 2019 Jun; 1865(6):1351-1360. PubMed ID: 30742993
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Analysis of glomerulosclerosis and atherosclerosis in lecithin cholesterol acyltransferase-deficient mice.
    Lambert G; Sakai N; Vaisman BL; Neufeld EB; Marteyn B; Chan CC; Paigen B; Lupia E; Thomas A; Striker LJ; Blanchette-Mackie J; Csako G; Brady JN; Costello R; Striker GE; Remaley AT; Brewer HB; Santamarina-Fojo S
    J Biol Chem; 2001 May; 276(18):15090-8. PubMed ID: 11278414
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Current Status of Familial LCAT Deficiency in Japan.
    Kuroda M; Bujo H; Yokote K; Murano T; Yamaguchi T; Ogura M; Ikewaki K; Koseki M; Takeuchi Y; Nakatsuka A; Hori M; Matsuki K; Miida T; Yokoyama S; Wada J; Harada-Shiba M
    J Atheroscler Thromb; 2021 Jul; 28(7):679-691. PubMed ID: 33867422
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of plasma and liver cholesterol- and lipoprotein-metabolism determinants in LpX formation in the mouse.
    Bravo I; Amigo L; Cohen DE; Nervi F; Rigotti A; Francone O; Zanlungo S
    Biochim Biophys Acta; 2007 Jun; 1770(6):979-88. PubMed ID: 17399905
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Abnormal Lipoproteins Trigger Oxidative Stress-Mediated Apoptosis of Renal Cells in LCAT Deficiency.
    Gomaraschi M; Turri M; Strazzella A; Lhomme M; Pavanello C; Le Goff W; Kontush A; Calabresi L; Ossoli A
    Antioxidants (Basel); 2023 Jul; 12(8):. PubMed ID: 37627492
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Lecithin:Cholesterol Acyltransferase Deficiency, from genes to therapy].
    Lucca F; Ossoli A; Boscutti G; Franceschini G; Calabresi L
    G Ital Nefrol; 2016 Malattie Metaboliche e Rene; 33(S68):. PubMed ID: 27960011
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lecithin:Cholesterol Acyltransferase Activation by Sulfhydryl-Reactive Small Molecules: Role of Cysteine-31.
    Freeman LA; Demosky SJ; Konaklieva M; Kuskovsky R; Aponte A; Ossoli AF; Gordon SM; Koby RF; Manthei KA; Shen M; Vaisman BL; Shamburek RD; Jadhav A; Calabresi L; Gucek M; Tesmer JJG; Levine RL; Remaley AT
    J Pharmacol Exp Ther; 2017 Aug; 362(2):306-318. PubMed ID: 28576974
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Safety and Tolerability of ACP-501, a Recombinant Human Lecithin:Cholesterol Acyltransferase, in a Phase 1 Single-Dose Escalation Study.
    Shamburek RD; Bakker-Arkema R; Shamburek AM; Freeman LA; Amar MJ; Auerbach B; Krause BR; Homan R; Adelman SJ; Collins HL; Sampson M; Wolska A; Remaley AT
    Circ Res; 2016 Jan; 118(1):73-82. PubMed ID: 26628614
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mice overexpressing human lecithin: cholesterol acyltransferase are not protected against diet-induced atherosclerosis.
    Mehlum A; Muri M; Hagve TA; Solberg LA; Prydz H
    APMIS; 1997 Nov; 105(11):861-8. PubMed ID: 9393557
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Novel lecithin: cholesterol acyltransferase-based therapeutic approaches.
    Freeman LA; Karathanasis SK; Remaley AT
    Curr Opin Lipidol; 2020 Apr; 31(2):71-79. PubMed ID: 32073411
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Amelioration of circulating lipoprotein profile and proteinuria in a patient with LCAT deficiency due to a novel mutation (Cys74Tyr) in the lid region of LCAT under a fat-restricted diet and ARB treatment.
    Naito S; Kamata M; Furuya M; Hayashi M; Kuroda M; Bujo H; Kamata K
    Atherosclerosis; 2013 May; 228(1):193-7. PubMed ID: 23522979
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification and functional analysis of missense mutations in the lecithin cholesterol acyltransferase gene in a Chilean patient with hypoalphalipoproteinemia.
    Tobar HE; Cataldo LR; González T; Rodríguez R; Serrano V; Arteaga A; Álvarez-Mercado A; Lagos CF; Vicuña L; Miranda JP; Pereira A; Bravo C; Aguilera CM; Eyheramendy S; Uauy R; Martínez Á; Gil Á; Francone O; Rigotti A; Santos JL
    Lipids Health Dis; 2019 Jun; 18(1):132. PubMed ID: 31164121
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tissue-specific expression of the human gene for lecithin: cholesterol acyltransferase in transgenic mice alters blood lipids, lipoproteins and lipases towards a less atherogenic profile.
    Mehlum A; Staels B; Duverger N; Tailleux A; Castro G; Fievet C; Luc G; Fruchart JC; Olivecrona G; Skretting G
    Eur J Biochem; 1995 Jun; 230(2):567-75. PubMed ID: 7607230
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In vitro expression of natural mutants of human lecithin:cholesterol acyltransferase.
    Qu SJ; Fan HZ; Blanco-Vaca F; Pownall HJ
    J Lipid Res; 1995 May; 36(5):967-74. PubMed ID: 7658168
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A systematic review of the natural history and biomarkers of primary lecithin:cholesterol acyltransferase deficiency.
    Vitali C; Bajaj A; Nguyen C; Schnall J; Chen J; Stylianou K; Rader DJ; Cuchel M
    J Lipid Res; 2022 Mar; 63(3):100169. PubMed ID: 35065092
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Markedly accelerated catabolism of apolipoprotein A-II (ApoA-II) and high density lipoproteins containing ApoA-II in classic lecithin: cholesterol acyltransferase deficiency and fish-eye disease.
    Rader DJ; Ikewaki K; Duverger N; Schmidt H; Pritchard H; Frohlich J; Clerc M; Dumon MF; Fairwell T; Zech L
    J Clin Invest; 1994 Jan; 93(1):321-30. PubMed ID: 8282802
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.